婴儿幽门肌切开术预防性抗生素使用与结局:多中心倾向匹配队列分析
倾向匹配分析显示预防性抗生素未显著降低手术部位感染率(aOR 0.61,95%CI 0.37-1.01),医院层面预防率与SSI O/E率比无相关性;亚组分析显示腹腔镜手术无获益,但开腹手术SSI显著降低(aOR 0.36,95%CI 0.14-0.93)。结论提示常规预防性抗生素不降低腹腔镜幽门肌切开术SSI率,但开腹手术可考虑选择性预防。
要点
- 腹腔镜幽门肌切开术婴儿预防性抗生素未显著降低SSI率(aOR 0.96,95%CI 0.55-1.69)。
- 开腹幽门肌切开术婴儿预防性抗生素显著降低SSI率(aOR 0.36,95%CI 0.14-0.93)。
- 医院层面预防性抗生素使用率与SSI O/E率比无显著相关性(Spearman ρ=0.11,P=0.13)。
核心结论
- 常规预防性抗生素不降低腹腔镜幽门肌切开术婴儿的SSI率,但开腹手术中观察到SSI显著降低,提示该高风险队列可考虑选择性预防。
主要发现
- 倾向匹配分析中SSI率无预防组为38/2591(1.6%),预防组为28/2591(1.1%),aOR 0.61(95%CI 0.37-1.01)。
- 医院层面预防性抗生素使用率与SSI O/E率比无显著相关性(Spearman ρ=0.11,P=0.13)。
- 腹腔镜亚组SSI率预防组24/2288(1.1%) vs 无预防组25/2288(1.1%),aOR 0.96(95%CI 0.55-1.69)。
- 开腹亚组SSI率预防组6/311(1.9%) vs 无预防组16/311(5.1%),aOR 0.36(95%CI 0.14-0.93)。
临床怎么用
- 腹腔镜幽门肌切开术婴儿不推荐常规使用预防性抗生素。
- 开腹幽门肌切开术婴儿可考虑选择性使用预防性抗生素以降低SSI风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes in infants undergoing pyloromyotomy who did and did not receive antimicrobial prophylaxis. SUMMARY BACKGROUND DATA: Variation exists among pediatric surgeons in the perceived utility and use of prophylactic antibiotics for infants undergoing pyloromyotomy. METHODS: We conducted a multicenter study of infants undergoing pyloromyotomy at 148 hospitals participating in NSQIP-Pediatric from January 2021 to December 2023. Outcomes were compared using patient-level propensity-matched mixed-effects models, adjusting for hospital clustering. A complementary hospital-level analysis assessed the correlation between institutional prophylaxis rates and observed-to-expected (O/E) surgical site infection (SSI) rate ratios. RESULTS: 6093 infants were included, of which 46.6% received prophylaxis. In the propensity-matched analysis, outcomes were similar for SSI (no prophylaxis: 38/2591 [1.6%] vs. prophylaxis: 28/2591 [1.1%], aOR 0.61; 95% CI, 0.37-1.01) and higher rates of prophylaxis use were not correlated with lower SSI O/E rate ratios in the hospital-level analysis (Spearman ρ = 0.11; P = 0.13). In propensity-matched subgroup analyses stratified by operative approach, no benefit was observed in the use of prophylaxis in infants undergoing laparoscopic pyloromyotomy (prophylaxis: 24/2288 [1.1%] vs. no prophylaxis: 25/2288 [1.1%]; aOR, 0.96; 95% CI, 0.55-1.69); however, a significant reduction in SSI rates was observed with open repair (prophylaxis: 6/311 [1.9%] vs. no prophylaxis: 16/311 [5.1%]; aOR 0.36; 95% CI, 0.14-0.93). CONCLUSIONS: Routine prophylaxis use does not reduce SSI rates in infants undergoing laparoscopic pyloromyotomy; however, a significant reduction in SSI was observed in infants undergoing open repair, suggesting selective prophylaxis is indicated in this higher-risk cohort.
引用
- McKie KA, Moturu A, Graham DA, et al. Prophylactic Antibiotic use and Outcomes in Infants Undergoing Pyloromyotomy: A Multicenter Propensity Matched Cohort Analysis. Ann Surg. 2025. PMID: 40539274. doi:10.1097/SLA.0000000000006806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。